| 产品名称： | Histoplasma capsulatum Darling |
|---|---|
| 商品货号： | TS139140 |
| Deposited As： | Histoplasma capsulatum Darling, anamorph |
| Strain Designations： | 224-A 1106 |
| Alternate State： | Ajellomyces capsulatus (Kwon-Chung) McGinnis et Katz, teleomorph |
| Application： | Biomedical Research and Development Material Emerging infectious disease research Respiratory research |
| Biosafety Level： | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Mycelial form Antifungal properties of cycloheximide Isolation and in vitro antifungal activity of 6,6-dihydroxythiobinupharidine |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | MA Gordon |
| Isolation： | human bone marrow, New York |
| References： | Salkin IF. Dermatophyte test medium: evaluation with nondermatophytic pathogens. Appl. Microbiol. 26: 134-137, 1973. PubMed: 4795526 Salkin IF, Hurd N. Quantitative evaluation of the antifungal properties of cycloheximide. Antimicrob. Agents Chemother. 1: 177-184, 1972. PubMed: 5065214 Cullen WP, et al. Isolation and in vitro antifungal activity of 6,6- dihydroxythiobinupharidine. J. Pharm. Sci. 62: 826-827, 1973. PubMed: 4574588 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Histoplasma capsulatum Darling |
|---|---|
| 商品货号： | TS139140 |
| Deposited As： | Histoplasma capsulatum Darling, anamorph |
| Strain Designations： | 224-A 1106 |
| Alternate State： | Ajellomyces capsulatus (Kwon-Chung) McGinnis et Katz, teleomorph |
| Application： | Biomedical Research and Development Material Emerging infectious disease research Respiratory research |
| Biosafety Level： | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Mycelial form Antifungal properties of cycloheximide Isolation and in vitro antifungal activity of 6,6-dihydroxythiobinupharidine |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | MA Gordon |
| Isolation： | human bone marrow, New York |
| References： | Salkin IF. Dermatophyte test medium: evaluation with nondermatophytic pathogens. Appl. Microbiol. 26: 134-137, 1973. PubMed: 4795526 Salkin IF, Hurd N. Quantitative evaluation of the antifungal properties of cycloheximide. Antimicrob. Agents Chemother. 1: 177-184, 1972. PubMed: 5065214 Cullen WP, et al. Isolation and in vitro antifungal activity of 6,6- dihydroxythiobinupharidine. J. Pharm. Sci. 62: 826-827, 1973. PubMed: 4574588 |
